Asymmetric Synthesis with Strained Molceules

应变分子的不对称合成

基本信息

  • 批准号:
    7086787
  • 负责人:
  • 金额:
    $ 25.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-05 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The development of new reactions for organic synthesis is at the core of health related fields such as drug discovery, process chemistry, natural products synthesis and biologically inspired molecular design. While the state of the art is such that remarkably complex molecules can be synthesized given ample time and skilled personnel, there persists a need for tandem reactions that couple simple partners to selectively produce complex products. The goal of this research program is to harness the unusual reactivity of high strain molecules to quickly generate molecules that are rich in stereochemical complexity and structural diversity. These 'strain assisted' reactions include directed nucleophilic addition/capture sequences and cycloaddition reactions of cyclopropenes and bicyclobutanes. In order for the methodology to have broad utility, it is explicitly necessary to develop asymmetric and enantioselective syntheses and reactions. While the exploratory stages of any program in synthetic methodology rely on screening, the refinement stage of each method will rely heavily on mechanistic analysis. The applications of this research are threefold: 1) the development of new synthetic methods that will have broad utility because they address fundamental, unsolved problems; 2) the development of unnatural amino acids with applications in environmentally responsive biomaterials; 3) the use of strained molecules in the syntheses of alkaloids with all-carbon quaternary centers and in the synthesis of pycnocomolide - a 12-deoxy-16-hydroxyphorbol natural product that is a potent activator of PKC and a target as a cancer drug. The syntheses of computationally designed pycnocomolide analogs are also proposed.
描述(由申请人提供):有机合成新反应的开发是健康相关领域的核心,如药物发现,过程化学,天然产物合成和生物学启发的分子设计。虽然目前的技术水平是这样的,只要有足够的时间和熟练的人员,就可以合成非常复杂的分子,但仍然需要串联反应,将简单的伙伴偶联起来,有选择地生产复杂的产物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH M FOX其他文献

JOSEPH M FOX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH M FOX', 18)}}的其他基金

Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    9899272
  • 财政年份:
    2019
  • 资助金额:
    $ 25.8万
  • 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    10660115
  • 财政年份:
    2019
  • 资助金额:
    $ 25.8万
  • 项目类别:
NIH ADMINISTRATIVE SUPPLEMENT FPLC SYSTEM FOX
NIH 行政补充 FPLC 系统 FOX
  • 批准号:
    9925864
  • 财政年份:
    2019
  • 资助金额:
    $ 25.8万
  • 项目类别:
Supplement to Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包的补充
  • 批准号:
    10046448
  • 财政年份:
    2019
  • 资助金额:
    $ 25.8万
  • 项目类别:
Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry
快速、多用途和诱导生物正交化学工具包
  • 批准号:
    10343710
  • 财政年份:
    2019
  • 资助金额:
    $ 25.8万
  • 项目类别:
Discovery of Molecular Probes and Therapeutic Leads, Administrative Supplement for Equipment
分子探针和治疗先导物的发现,设备管理补充
  • 批准号:
    10400299
  • 财政年份:
    2014
  • 资助金额:
    $ 25.8万
  • 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase 2
化学探针和治疗先导化合物的发现,第二阶段
  • 批准号:
    10853967
  • 财政年份:
    2014
  • 资助金额:
    $ 25.8万
  • 项目类别:
Fox COBRE Phase II Admin Core
Fox COBRE 第二阶段管理核心
  • 批准号:
    10026269
  • 财政年份:
    2014
  • 资助金额:
    $ 25.8万
  • 项目类别:
Discovery of Chemical Probes and Therapeutic Leads, Phase II
化学探针和治疗先导化合物的发现,第二阶段
  • 批准号:
    10654734
  • 财政年份:
    2014
  • 资助金额:
    $ 25.8万
  • 项目类别:
Fox COBRE Phase II Admin Core
Fox COBRE 第二阶段管理核心
  • 批准号:
    10654735
  • 财政年份:
    2014
  • 资助金额:
    $ 25.8万
  • 项目类别:

相似海外基金

Asymmetric Single-Chain MspA nanopores for electroosmotic stretching and sequencing proteins
用于电渗拉伸和蛋白质测序的不对称单链 MspA 纳米孔
  • 批准号:
    10646810
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Exploring the Role of Nitrogen Metabolism in Cancer
探索氮代谢在癌症中的作用
  • 批准号:
    10737792
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Discovery of neoepitope immunotherapeutic targets in diffuse pediatric high-grade gliomas
弥漫性儿童高级别胶质瘤中新表位免疫治疗靶点的发现
  • 批准号:
    10774404
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Detecting cell to cell contacts in zebrafish with a synthetic receptor methodology
使用合成受体方法检测斑马鱼的细胞与细胞接触
  • 批准号:
    10645331
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
  • 批准号:
    10698746
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
  • 批准号:
    10713648
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Identifying the Molecular Function of the Y-linked Mouse Zinc Finger Proteins ZFY1 and ZFY2
鉴定 Y 连锁小鼠锌指蛋白 ZFY1 和 ZFY2 的分子功能
  • 批准号:
    10749409
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
  • 批准号:
    10589578
  • 财政年份:
    2023
  • 资助金额:
    $ 25.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了